Pacira BioSciences Inc

NASDAQ:PCRX   10:16:14 AM EDT
58.70
+0.58 (+1.00%)
Earnings Announcements

Pacira Biosciences Reports Second Quarter 2022 Financial Results

Published: 08/03/2022 12:57 GMT
Pacira BioSciences Inc (PCRX) - Pacira Biosciences Reports Second Quarter 2022 Financial Results.
Q2 GAAP Earnings per Share $0.40.
Q2 Revenue $169.4 Million.
Q2 2022 Total Revenues of $169.4 Million.
Ended Q2 of 2022 With Cash, Cash Equivalents and Short-term Available-for-sale Investments of $316.4 Million.
Q2 Earnings per Share View $0.85, Revenue View $170.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $172.44 Million
Adjusted EPS is expected to be $0.83

Next Quarter Revenue Guidance is expected to be $192.87 Million
Next Quarter EPS Guidance is expected to be $1.16

More details on our Analysts Page.